News and communications

DASA seeks innovations to provide protection for land based assets from air attacks

• Updated: 17 April 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A

• Updated: 9 April 2024

Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.

• Updated: 5 April 2024

Charges for NHS prescriptions, wigs and fabric supports will increase on 1 May 2024.

• Updated: 5 April 2024

Ventilators, oxygen concentrators, pumps and monitors among kit donated to Ukraine.

• Updated: 5 April 2024

The MHRA has approved the combined antibiotic cefepime/enmetazobactam (Exblifep 2 g/0.5 g powder for concentrate for solution for infusion)

• Updated: 4 April 2024

Following MHRA approval of a clinical trial, early breast cancer patients on endocrine-based therapy can benefit from a study with camizestrant.

• Updated: 28 March 2024

The move will streamline processes within dental and pharmacy settings and improve patient experiences.

• Updated: 28 March 2024

Thousands of counterfeit or unbranded copies of LifeVac anti-choking devices are being sold across the UK. The public is reminded to check their product carefully against the images in MHRA guidance to identify whether it is…

• Updated: 25 March 2024

Scott Mitchell appointed People’s Champion of the national mission to beat dementia, founded in his wife Dame Barbara Windsor’s memory.

• Updated: 20 March 2024

A company director and his pharmaceutical manufacturing company were sentenced in court today after pleading guilty to two charges of falsifying data that supported the shelf life of a medicine, adversely affecting its quali…

• Updated: 15 March 2024

The UK suspension of the MAGEC system (modified MAGEC X system only) has been lifted as of 23 February 2024

• Updated: 12 March 2024

The MHRA welcomes the publication of Dame Margaret Whitehead’s Equity in Medical Devices: Independent Review

• Updated: 11 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine quizartinib (Vanflyta) to be used alongside chemotherapy as first line treatment for adults who have acute myeloi…

• Updated: 11 March 2024

Millions at risk from 'silent killer' as NHS campaign warns there are often 'no clues' when it comes to high blood pressure. 

• Updated: 11 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.

• Updated: 11 March 2024

Government outlines action to make UK a world leader in tackling ethnic and other biases in medical devices.

• Updated: 11 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine ganaxolone (Ztalmy) as the first anti-seizure medication in the UK to treat cyclin-dependent kinase-like 5 (CDKL5)…

• Updated: 7 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (7 March 2024) approved the medicine rozanolixizumab (Rystiggo) to treat adults with generalised myasthenia gravis, an autoimmune disease that causes m…

• Updated: 7 March 2024

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (6 March 2024) approved the medicine piflufolastat (18F) (Pylclari) as a diagnostic tool for people with suspected or known prostate cancer.

• Updated: 6 March 2024